Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer
Abstract Previous small-size studies reported BRAF-mutated NSCLC patients have comparable sensitivity to immune checkpoint inhibitors (ICIs). However, how BRAF mutation affects the tumor immune microenvironment (TIME) is unknown. We performed Nanostring-panel RNA sequencing to evaluate TIME in 57 BR...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2022-12-01
|
| Serie: | Cell Death and Disease |
| Accesso online: | https://doi.org/10.1038/s41419-022-05510-4 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|